Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Coronary Physiology Is Useful in Chronic Kidney Disease

Coronary physiology, FFR and iFR, has been shown safe to defer lesions and effective to save stents by different randomized studies and registries. However, patients with chronic kidney disease have not been thoroughly analyzed yet, which brings us to the question about what to do in the face of their negative evolution, when atherosclerosis develops faster, and stress tests are required before we would normally expect.

taller de imágenes y fisiología intracoronaria

This is a retrospective study including 439 patients. 319 (72.7%) presented conserved kidney function assessed with glomerular filtration (eGFR > 60 mL/min/1.73 m2,), and 120 showed evidence of chronic kidney disease (CKD) (glomerular filtration eGFR < 60 mL/min/1.73 m2).

251 patients with conserved kidney function were deferred with FFR (78,7%) and 78 with iFR (21,3%), while 94 CKD patients were deferred with FFR (78,3%) and 26 with iFR (21,7%).

Primary end point was a composite of all cause death, MI or unplanned revascularization. Secondary end point was all cause death, cardiac death, MI and unplanned revascularization. 

Patients with CKD were older, and presented more hypertension, diabetes, peripheral vascular disease and use of anticoagulation, but lower use of ASA. 

Read also: Tricuspid Regurgitation: Edge-to-Edge Treatment with PASCAL.

There were no differences in number of interrogated lesions or their location. The left anterior descending artery was the most involved. 

FFR was used 80% of times.

After 4 years, primary end point was higher in patients with CKD (25% vs. 14% p=0.01). Also, all-cause mortality (13.3% vs. 5.3%, p=0.006) and cardiovascular mortality (5.8% vs. 1.3% p=0.01) were higher. Unplanned revascularization was also higher, though not significantly. There were no differences in MI or target vessel related MI. 

Read also: Progress-CTO Score: A Key New Tool to Plan CTO.

Patients with 4 or 5 stage CKD presented more events vs. patients with conserved kidney function.

Evolution was analyzed according to lesion assessment strategy and there were no differences between FFR and iFR.

Conclusion

Patients with CKD and deferred coronary lesions after pressure-wire evaluation develop more events in the long term compared against patients presenting conserved kidney function. However, this increased number of events in CDK patients was rarely related to the deferred vessel, which suggests an epiphenomenon of intrinsically higher cardiovascular risk in CKD patients.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Safety of coronary revascularization deferral based on fractional flow reserve and instantaneous wave-free ratio in patients with chronic kidney disease.

Reference: Alejandro Travieso, et al. Cardiol J 2022, 29, 4: 553–562.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....